TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TAP Biosystems Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12344
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a provider of laboratory and pharmaceutical equipment. The company designs and manufactures automated cell culture, bio-reactor systems and fermentation systems. It also provides labware, consumables and accessories. TAP offers services such as installation, onsite repair services, preventative maintenance, operator and maintenance training, system and software upgrades, preventive maintenance visits, lab relocations and decommissioning, protocol development, customer support, and validation and GMP compliance. The company’s products find application in drug discovery, biologics production, bioprocess development, regenerative medicine and tissue engineering. It partners with distribution companies. It has operations in Royston, the UK; and Wilmington, the US. TAP is headquartered in Royston, the UK.

TAP Biosystems Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
Licensing Agreements 16
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Acquisition 17
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd – Key Competitors 19
TAP Biosystems Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Key Facts 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TAP Biosystems Enters into Agreement with Cell Therapy Catapult 11
TAP Biosystems Enters Into Co-Development Agreement With Life Technologies For Protein Expression Platform 12
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 13
TAP Biosystems Enters Into Co-Development Agreement With University College London 14
TAP Biosystems Enters Into Co-Development Agreement With Open University 15
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 16
Sartorius Stedim Biotech Acquires TAP Biosystems for USD44.7 Million 17
TAP Biosystems Ltd, Key Competitors 19
TAP Biosystems Ltd, Other Locations 20

List of Figures
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TAP Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TAP Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) operates as a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cem …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Halozyme Therapeutics Inc (HALO):製薬・医療:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Netmedia S.A.:企業の戦略・SWOT・財務分析
    Netmedia S.A. - Strategy, SWOT and Corporate Finance Report Summary Netmedia S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mr. Price Group Ltd.:戦略・SWOT・企業財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ebix Inc:企業のM&A・事業提携・投資動向
    Ebix Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ebix Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Futuren (FTRN):電力:M&Aディール及び事業提携情報
    Summary Futuren, previously Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The com …
  • Teva Pharmaceutical Industries Limited:企業の戦略・SWOT・財務情報
    Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Kyivstar JSC:企業の戦略的SWOT分析
    Kyivstar JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • PHX Energy Services Corp (PHX):企業の財務・戦略的SWOT分析
    Summary PHX Energy Services Corp (PHX Energy), formerly Phoenix Technology Income Fund is an energy service company that manufactures, designs, and engineers directional drilling technologies. The corporation’s equipment includes RADD, P-360 MWD, E-360 MWD, 360 RWD, and performance motors and others …
  • K-Electric Ltd:発電所・企業SWOT分析
    K-Electric Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Karoon Energy Ltd (KAR):企業の財務・戦略的SWOT分析
    Karoon Energy Ltd (KAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • ERG SpA (ERG)-エネルギー分野:企業M&A・提携分析
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …
  • Vestas Wind Systems AS (VWS)-エネルギー分野:企業M&A・提携分析
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • Sunkist Growers, Inc.:企業の戦略的SWOT分析
    Sunkist Growers, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Associated Alcohols & Breweries Limited.:企業の戦略・SWOT・財務情報
    Associated Alcohols & Breweries Limited. - Strategy, SWOT and Corporate Finance Report Summary Associated Alcohols & Breweries Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • PECO Energy Co:企業の戦略的SWOT分析
    PECO Energy Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆